Around 10 years ago, there was a series of publications suggesting a link between the use of serotonin reuptake inhibitor antidepressants and bone loss in older women. One of the things that made it difficult [...]
While numerous published studies have investigated the impact of treatments for major depressive disorder (MDD) in pregnancy on maternal and neonatal outcomes, few studies have examined the perinatal effects of anxiety disorders such as generalized [...]
In a study including Latin American women 40 to 59 years of age who had not menstruated for more than 1 year (or had undergone a bilateral oophorectomy), 49.1% of the participants were depressed and [...]
In a recent cross-sectional study from Denmark, researchers compared the prevalence of stress and depressive symptoms among 301 women with recurrent pregnancy loss (or RPL) and 1813 women attempting to conceive naturally. RPL was defined [...]
While many women complain of psychological distress during infertility treatment, it has been somewhat unclear if the anxiety and depression women may experience is related to having to undergo infertility treatment or to the hormonal agents that are used as part of the treatment, or a combination of the two. While we know that changing levels of gonadal hormones, like estrogen, may affect mood and anxiety levels, we have very little information on the psychological effects of the hormone-modulating drugs used in assisted reproductive technology (ART).
During pregnancy, many women complain that they feel more forgetful or less sharp than before their pregnancy.
Women who take antidepressants for their depression must make a difficult decision when they plan to become pregnant. Should they continue their medication during pregnancy? Or should they stop? Although there is information to support the reproductive safety of at least some antidepressants, most women, understandably concerned about exposing their babies to medication, choose to discontinue their antidepressant during pregnancy.